P582 Efficacy of etrasimod at week 52 among subjects who reached clinical response at week 12: post hoc analysis of the phase 3 ELEVATE UC 52 trial

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalJournal of Crohn's and Colitis
DOIs
Publication statusPublished - 2023

Keywords

  • Medicine
  • Post-hoc analysis
  • Post hoc
  • Internal medicine
  • Clinical trial
  • Placebo
  • Gastroenterology
  • Clinical endpoint
  • Ulcerative colitis
  • Disease
  • Alternative medicine
  • Pathology

Cite this